Fig. 1From: Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trialStudy design. a Informed consent was obtained before day − 80. b Visits 2 and 3 occurred on days 1–5 of the menstrual cycleBack to article page